Ankush Kawali,B Rashmi,Sai B Mishra et al.
Ankush Kawali et al.
Post-laminar optic nerve invasion in the presence of scleral invasion: Case for intensive adjuvant treatment in retinoblastoma [0.03%]
脉络膜受侵继发视神经 retina-blstoma的术后处理需谨慎
Rachna Meel,Keerthana Kasi,Seema Kashyap et al.
Rachna Meel et al.
Authors' Response: Posterior subtenon interferon alfa-2B injection in inflammatory macular edema [0.03%]
作者回复：后巩膜下干扰素阿尔法-2b注射在炎症性黄斑水肿中的应用
Ankush Kawali,Sai B Mishra,Padmamalini Mahendradas et al.
Ankush Kawali et al.
Comment on: Efficacy and safety of posterior subtenon interferon alfa-2B injection in recurrent inflammatory macular edema [0.03%]
后部巩膜上腔注射干扰素α-2B治疗复发性炎症性黄斑水肿的疗效及安全性：-comment
Harshal Sahare,H Anupama
Harshal Sahare
Authors' Response comment on Comparative analysis of retinal thickness between type 1 and type 2 diabetes Mellitus patients with similar disease duration - A cross-sectional study [0.03%]
糖尿病病程相同的情况下初发型和继发型糖尿病患者视网膜厚度比较研究——一项回顾性病例观察分析作者答复
Shalvika Gupta,Vijaya Sahu,Amritava Ghosh et al.
Shalvika Gupta et al.
Comments on "Comparative analysis of retinal thickness between type 1 and type 2 diabetes mellitus patients with similar disease duration: A cross-sectional study" [0.03%]
短病程的1型糖尿病与2型糖尿病黄斑区及视网膜厚度比较的横断面研究述评
Priyanka Vazrala,Syed Ali Nasar Waris,Rubina Huda et al.
Priyanka Vazrala et al.
Response to comments on "Intravitreal triamcinolone acetonide therapy in serpiginous-like choroiditis" [0.03%]
关于“类塞里佩ジ氏病的玻璃体内曲安奈德治疗”的评论回复
Ankush Kawali,Sai Bhakti Mishra,Padmamalini Mahendradas
Ankush Kawali
Artificial intelligence in diabetic macular edema: Expanding clinical vision [0.03%]
人工智能在糖尿病黄斑水肿中的应用：拓展临床视野
Aditya Barigali
Aditya Barigali
Management strategies in acute postcataract endophthalmitis: Insights from a 10-year real-world experience [0.03%]
基于10年真实世界经验的急性白内障术后终末期瘭肉炎管理策略的启示
Aditya Kelkar,Rabia Naaz,Harsh H Jain et al.
Aditya Kelkar et al.